Radiation Sickness News and Research

RSS

Ohio State researchers enter federal cooperative agreement to develop radiation biodosimetry solutions

Researchers with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) have entered a federal cooperative agreement, valued up to $9.42 million, that will help them further develop Ohio State's biodosimetry technology to discover noninvasive biomarkers for radiation exposure – work that will have national security applications.

2 Nov 2022

New test uses a single drop of blood to rapidly detect radiation sickness

A new proof-of-concept study reports evidence that a new testing method has the potential to rapidly identify radiation sickness based on biomarkers measured through a single drop of blood.

15 Jul 2020

FDA grants Orphan Drug Designation to Myelo001 for treatment of Acute Radiation Syndrome

Myelo Therapeutics GmbH announced today that the US Food and Drug Administration has granted an Orphan Drug Designation to its orally applied new chemical entity Myelo001 for the treatment of Acute Radiation Syndrome.

25 Sep 2018

Non-ionizing radiation from magnetic fields could have adverse biological impacts on health

A study of real-world exposure to non-ionizing radiation from magnetic fields in pregnant women found a significantly higher rate of miscarriage, providing new evidence regarding their potential health risks.

13 Dec 2017

Scientists uncover stem cell response to prolonged irradiation

Researchers from several Russian institutes, including MIPT, have found out how prolonged exposure to ionizing radiation affects human stem cells.

24 Aug 2017

Manganese-based antioxidant complex of Deinococcus protects mice from gamma radiation

They call it "Conan the Bacterium," and now it may be used to help save lives in the event of a nuclear disaster or terrorist attack.

9 Aug 2016

Low levels of radiation exposure does not affect health, study finds

Researchers in Europe have reviewed cancer rates among people in parts of the world where natural background radiation is higher than average and found that incidence is not as high as one might guess. The findings, published in the International Journal of Low Radiation suggests that science ought to take a second look at studies that correlate low levels of radiation exposure with detrimental health effects

16 Mar 2016

MIPT scientists reveal that weak gamma radiation doses prolong life of female fruit flies

Scientists at MIPT have revealed that weak doses of gamma radiation prolong the life of drosophila flies (fruit flies), and that the effect is stronger in females than in males. These findings could reveal the genes that enable the prolongation of life and in the future lead to the creation of a means to prevent aging in humans.

24 Aug 2015

SignaBlok's novel peptide inhibitor of TREM-1 suppresses cancer progression

SignaBlok, Inc., a Massachusetts-based biopharmaceutical company, today announced the successful in vivo proof of concept data that demonstrate that the company's novel mechanism-based, first-in-class peptide inhibitor of TREM-1 effectively suppresses cancer progression in mouse models of lung cancer and dramatically improves survival in septic mice.

18 Sep 2013

Harvard University receives grant to use organs-on-chips device to test human response to radiation

A team at the Wyss Institute for Biologically Inspired Engineering at Harvard University has received a $5.6 million grant award from the United States Food and Drug Administration (FDA) to use its Organs-on-Chips technology for a novel application of keen interest to national security and health officials: to test human physiological responses to radiation, and to evaluate drugs designed to counter those effects.

13 Aug 2013

Two-drug combination may alleviate radiation sickness in people

A combination of two drugs may alleviate radiation sickness in people who have been exposed to high levels of radiation, even when the therapy is given a day after the exposure occurred, according to a study led by scientists from Dana-Farber Cancer Institute and Children's Hospital Boston.

24 Nov 2011

Acetyl resveratrol could protect against radiation sickness

In the midst of ongoing concerns about radiation exposure from the Fukushima nuclear power plant in Japan, scientists are reporting that a substance similar to resveratrol - an antioxidant found in red wine, grapes and nuts - could protect against radiation sickness. The report appears in ACS Medicinal Chemistry Letters.

5 May 2011

Oncologist issues 'Emergency Radiation Medical Handbook'

Quickly responding to international demand due to Japan's disabled nuclear power reactors, James W. Forsythe, M.D., H.M.D., has issued an "Emergency Radiation Medical Handbook" for use worldwide.

2 Apr 2011

Elsevier announces free online medical information and clinical reference support for Japan earthquake relief efforts

Elsevier, a world leader in health care and medical publishing and online solutions, today announced that following the devastating earthquake and tsunami that struck Japan on March 11, the company is providing free access to its primary online clinical reference tools - MD Consult and First Consult - to all IPs originating from Japan. Free access will be available through April, 2011. This effort is part of a new initiative to provide easily accessible focused resources in response to world events that present difficult medical challenges.

25 Mar 2011

Radiations from Japanese nuclear plants do not pose immediate risk to the U.S.

Airborne radiation from a meltdown at Japanese nuclear plants poses no immediate risk to the continental United States, say University of Maryland public health and atmospheric scientists.

17 Mar 2011

NIAID funds second study of Aeolus Pharmaceuticals' AEOL 10150 as potential countermeasure to GI-ARS

Aeolus Pharmaceuticals, Inc. announced today that a second study of its lead drug, AEOL 10150, has been initiated by the National Institutes of Health's (NIH), National Institute of Allergy and Infectious Diseases (NIAID) Radiation/Nuclear Medical Countermeasures development program as a countermeasure for radiation exposure to the gastrointestinal (GI) tract.

13 Apr 2010

AEOL 10150 increases regeneration of GI stem cells: NIAID study results

Aeolus Pharmaceuticals, Inc. announced today that recent experiments in preclinical models conducted by the National Institutes of Health’s (NIH), National Institute of Allergy and Infectious Diseases (NIAID) Radiation/Nuclear Medical Countermeasure Development program have shown that AEOL 10150 can effectively increase regeneration of gastro-intestinal (GI) stem cells, reduce the severity and duration of diarrhea and improve survival when administered at 24 hours after doses of total-body irradiation that produce the lethal GI syndrome.

23 Oct 2009

Scientists bridge the "terahertz gap"

Going through airport security can be such a hassle. Shoes, laptops, toothpastes, watches and belts all get taken off, taken out, scanned, examined, handled and repacked. But "T-rays", a completely safe form of electromagnetic radiation, may reshape not only airport screening procedures but also medical imaging practices.

27 Nov 2007

How polonium-210 acts as a poison in the body

The Health Protection Agency's radiation protection experts together with colleagues from research laboratories in the USA have published a paper in the Journal of Radiological Protection 1 on how polonium-210 acts as a poison in the body.

6 Mar 2007